I'm sure many of you saw that I was immediately correct on my nintendo call, despite how many negative things were said about my thesis and my pick.
Well, I'm back again with another play that'll make you money in short-order.
IBRX - Immunity Bio. I've been playing 2300 shares at $2.34 since last november. It's extremely cyclical between news catalysts. I admit... the best entry would have been yesterday and the day before if you weren't getting an entry like mine - but today is almost just as good of a day.
IBRX has received approvals for cancer treatments of various indications in 32 countries (including the UAE which announced approvals today)
They have ongoing trials for glioblastomas, lung cancer, and many other indications as well as massive infrastructure initiatives for distributing medical material.
Look at their earnings growth QoQ, YoY - we're not talking about baby percentages. We're talking multiples.
This stock benefits from everyone's favorite combination - it's an absolutely breakthrough company, and there's a massive, unjustified short float. It is literally one catalyst away from a true romance explosion, and their earnings are next week.
If you saw my last post about nintendo, you know I'm not going to use numbers to justify my position, that's up to you to google. I'm playing this, it has made me thousands of dollars, and it's going to make me thousands more. Join if you want.
Price targets -
(outside of squeeze action/normal movement goal) $20 by end of Q1 2027
(Short term squeeze limit) I've calculated with LLMs that the current float can squeeze as high as $60, with it predicting a "low peak" of $40.
you could sleep through the coming squeeze and still profit HUGE in the next couple of years.
(Not a financial advisor, post will be updated with future price action, play at your own risk)
**Price at time of post -=- 7.04**